Lipocine Future Growth
Future criteria checks 0/6
We currently don't have sufficient analyst coverage to forecast growth and revenue for Lipocine.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals earnings growth | 21.0% |
Revenue growth rate | n/a |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 12 Apr 2024 |
Recent future growth updates
Recent updates
Lipocine announces plans to focus on treating CNS disorders, shares rise ~5%
Sep 26Does Lipocine (NASDAQ:LPCN) Have A Healthy Balance Sheet?
Feb 22Is Lipocine (NASDAQ:LPCN) Using Debt Sensibly?
Sep 14Lipocine soars 9% on FDA greenlight for Phase 2 LPCN 1154 study in postpartum depression
Jun 14Lipocine competitor prevails in patent infringement lawsuit for Jatenzo
May 26When Will Lipocine Inc. (NASDAQ:LPCN) Turn A Profit?
May 11Lipocine EPS beats by $0.01
May 06Lipocine Inc. (NASDAQ:LPCN): Are Analysts Optimistic?
Jan 26Lipocine announces positive results from phase 2biopsy-confirmed NASH study
Jan 12FDA Ok's Lipocine's testosterone replacement therapy, tentatively
Dec 09Lipocine (NASDAQ:LPCN) Has Debt But No Earnings; Should You Worry?
Dec 04Lipocine EPS misses by $0.01
Nov 10Lipocine: TLANDO Might Become A Potential TRT Option In Patients With COVID-19 Infection
Nov 06Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2024 | 2 | -13 | N/A | N/A | 1 |
12/31/2023 | -3 | -16 | -12 | -12 | N/A |
9/30/2023 | -3 | -16 | -12 | -12 | N/A |
6/30/2023 | 0 | -12 | -12 | -12 | N/A |
3/31/2023 | 1 | -11 | -12 | -12 | N/A |
12/31/2022 | 1 | -11 | -12 | -12 | N/A |
9/30/2022 | 17 | 4 | -1 | -1 | N/A |
6/30/2022 | 17 | 3 | -5 | -5 | N/A |
3/31/2022 | 16 | -1 | -4 | -4 | N/A |
12/31/2021 | 16 | -1 | -4 | -4 | N/A |
9/30/2021 | 0 | -18 | -17 | -17 | N/A |
6/30/2021 | N/A | -19 | -14 | -14 | N/A |
3/31/2021 | N/A | -19 | -16 | -16 | N/A |
12/31/2020 | N/A | -21 | -15 | -15 | N/A |
9/30/2020 | N/A | -20 | -15 | -15 | N/A |
6/30/2020 | 0 | -18 | -14 | -14 | N/A |
3/31/2020 | 0 | -16 | -12 | -12 | N/A |
12/31/2019 | 0 | -13 | -12 | -12 | N/A |
9/30/2019 | 0 | -13 | -11 | -11 | N/A |
6/30/2019 | N/A | -12 | -11 | -11 | N/A |
3/31/2019 | N/A | -12 | -11 | -11 | N/A |
12/31/2018 | 0 | -12 | -12 | -12 | N/A |
9/30/2018 | 0 | -14 | -14 | -14 | N/A |
6/30/2018 | 0 | -16 | -15 | -15 | N/A |
3/31/2018 | 0 | -19 | -17 | -17 | N/A |
12/31/2017 | N/A | -21 | -17 | -17 | N/A |
9/30/2017 | N/A | -19 | N/A | -15 | N/A |
6/30/2017 | N/A | -17 | N/A | -14 | N/A |
3/31/2017 | N/A | -17 | N/A | -15 | N/A |
12/31/2016 | N/A | -19 | N/A | -18 | N/A |
9/30/2016 | N/A | -21 | N/A | -19 | N/A |
6/30/2016 | N/A | -24 | N/A | -20 | N/A |
3/31/2016 | N/A | -22 | N/A | -19 | N/A |
12/31/2015 | N/A | -18 | N/A | -15 | N/A |
9/30/2015 | N/A | -18 | N/A | -16 | N/A |
6/30/2015 | N/A | -15 | N/A | -13 | N/A |
3/31/2015 | N/A | -18 | N/A | -17 | N/A |
12/31/2014 | N/A | -20 | N/A | -17 | N/A |
9/30/2014 | N/A | -21 | N/A | -17 | N/A |
6/30/2014 | N/A | -20 | N/A | -18 | N/A |
3/31/2014 | N/A | -15 | N/A | -11 | N/A |
12/31/2013 | N/A | -11 | N/A | -9 | N/A |
9/30/2013 | 0 | -7 | N/A | -6 | N/A |
6/30/2013 | 0 | -4 | N/A | -3 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if LPCN's forecast earnings growth is above the savings rate (2.3%).
Earnings vs Market: Insufficient data to determine if LPCN's earnings are forecast to grow faster than the US market
High Growth Earnings: Insufficient data to determine if LPCN's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: Insufficient data to determine if LPCN's revenue is forecast to grow faster than the US market.
High Growth Revenue: Insufficient data to determine if LPCN's revenue is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if LPCN's Return on Equity is forecast to be high in 3 years time